369 related articles for article (PubMed ID: 37175726)
1. The Role of Microbiota-Derived Metabolites in Colorectal Cancer.
Duizer C; de Zoete MR
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175726
[TBL] [Abstract][Full Text] [Related]
2. The roles of microbial products in the development of colorectal cancer: a review.
Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota-derived metabolites in CRC progression and causation.
Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
[TBL] [Abstract][Full Text] [Related]
4. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
Sitkin SI; Tkachenko EI; Vakhitov TY
Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
[TBL] [Abstract][Full Text] [Related]
5. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
[TBL] [Abstract][Full Text] [Related]
6. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients.
Sánchez-Alcoholado L; Laborda-Illanes A; Otero A; Ordóñez R; González-González A; Plaza-Andrades I; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502456
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
Agus A; Clément K; Sokol H
Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
[TBL] [Abstract][Full Text] [Related]
8. Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease.
Masse KE; Lu VB
Front Endocrinol (Lausanne); 2023; 14():1169624. PubMed ID: 37560311
[TBL] [Abstract][Full Text] [Related]
9. Microbial metabolites as modulators of host physiology.
Joyce SA; Clarke DJ
Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
[TBL] [Abstract][Full Text] [Related]
11. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
[TBL] [Abstract][Full Text] [Related]
12. Microbial Metabolite Dysbiosis and Colorectal Cancer.
Niekamp P; Kim CH
Gut Liver; 2023 Mar; 17(2):190-203. PubMed ID: 36632785
[TBL] [Abstract][Full Text] [Related]
13. Differences in Fecal Gut Microbiota, Short-Chain Fatty Acids and Bile Acids Link Colorectal Cancer Risk to Dietary Changes Associated with Urbanization Among Zimbabweans.
Katsidzira L; Ocvirk S; Wilson A; Li J; Mahachi CB; Soni D; DeLany J; Nicholson JK; Zoetendal EG; O'Keefe SJD
Nutr Cancer; 2019; 71(8):1313-1324. PubMed ID: 31007075
[TBL] [Abstract][Full Text] [Related]
14. The influence of microbiota-derived metabolites on viral infections.
Alwin A; Karst SM
Curr Opin Virol; 2021 Aug; 49():151-156. PubMed ID: 34144380
[TBL] [Abstract][Full Text] [Related]
15. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.
Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L
J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome-metabolites axis: A friend or foe to colorectal cancer progression.
Wu H; Ma W; Wang Y; Wang Y; Sun X; Zheng Q
Biomed Pharmacother; 2024 Apr; 173():116410. PubMed ID: 38460373
[TBL] [Abstract][Full Text] [Related]
17. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
Sittipo P; Shim JW; Lee YK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
[TBL] [Abstract][Full Text] [Related]
18. Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis.
Fettig NM; Osborne LC
Microbes Infect; 2021; 23(6-7):104814. PubMed ID: 33775860
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
[TBL] [Abstract][Full Text] [Related]
20. "Driver-passenger" bacteria and their metabolites in the pathogenesis of colorectal cancer.
Avril M; DePaolo RW
Gut Microbes; 2021; 13(1):1941710. PubMed ID: 34225577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
